Oncology billing that masters chemotherapy administration, drug reimbursement, and complex modifiers so cancer practices protect every dollar of margin.
Oncology billing is uniquely high-stakes, combining expensive infused drugs, precise administration timing, and strict payer authorization requirements. ClaimSphere RCM deploys certified oncology coders who accurately capture drug units, administration hierarchies, and the modifiers that determine whether costly claims are paid in full.
Across medical, surgical, and radiation oncology, we manage prior authorizations, clean-claim submission, and aggressive denial recovery to safeguard thin drug margins. Our end-to-end approach shortens the revenue cycle and keeps your practice financially strong while your team focuses on patient care.
Accurate infusion and injection coding with correct initial, sequential, and concurrent administration hierarchy.
Precise J-code unit calculation and wastage documentation to protect margins on high-cost oncology drugs.
Proactive authorization for chemotherapy, radiation, and imaging to prevent denials on expensive services.
Correct coding of treatment planning, delivery, and management across the radiation therapy course.
Aggressive appeals and A/R follow-up on high-dollar denials that materially affect cash flow.
Infusion and injection services follow a strict hierarchy of initial, sequential, and concurrent administrations tied to start and stop times. We code these based on documented timing so each administration is captured correctly, which is critical for both compliance and full reimbursement.
Yes. When a single-dose vial is partially used, the discarded amount is billable with the JW modifier and proper documentation. We ensure wastage is captured accurately so your practice is reimbursed for the full cost of expensive oncology drugs.
We secure prior authorizations before treatment, verify J-code units against orders, and scrub claims for modifier and medical-necessity issues before submission. When denials do occur, our team pursues rapid, documented appeals because a single high-dollar oncology denial can significantly impact cash flow.
Get a free assessment of your revenue cycle from coders who know your specialty inside out.
Schedule a Consultation